Inventor · disambiguated record
Jimmy Van Wiltenburg
Also filed as: VAN WILTENBURG JIMMY
14 granted patents·8 pending applications·18 citations·filing 2011–2024
86Inventor score
Top patents by PatentIndex Score
22 records- 0191US11981667B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2022·Granted May 14, 2024·1 cites·8 claims
- 0290US11370776B2Sulfonylureas and sulfonylthioureas as NLRP3 inhibitorsINFLAZOME LTD·Filed 2018·Granted Jun 28, 2022·6 cites·19 claims
- 0383US11465992B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 11, 2022·1 cites·37 claims
- 0480US11834433B2CompoundsINFLAZOME LTD·Filed 2019·Granted Dec 5, 2023·2 cites·19 claims
- 0580US11518739B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Dec 6, 2022·2 cites·22 claims
- 0680US8410314B1Method of synthesisVAN WILTENBURG JIMMY·Filed 2011·Granted Apr 2, 2013·6 cites·10 claims
- 0779US2025115591A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2024·Application pending·0 cites
- 0858US2019194107A1Method of synthesisGREY PACIFIC LABS LLC·Filed 2018·Application pending·0 cites
- 0955US10150724B2Method of synthesis of methoxyheptyl bicyclooctanoneGREY PACIFIC LABS LLC·Filed 2017·Granted Dec 11, 2018·0 cites·9 claims
- 1052US12187702B2Sulfonamideurea compoundsINFLAZOME LTD·Filed 2019·Granted Jan 7, 2025·0 cites·8 claims
- 1152US11884645B2Sulfonyl acetamides as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Jan 30, 2024·0 cites·20 claims
- 1250US12168653B2Sulfonamide derivates as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Dec 17, 2024·0 cites·18 claims
- 1350US11530200B2CompoundsINFLAZOME LTD·Filed 2019·Granted Dec 20, 2022·0 cites·18 claims
- 1450US2022163539A1Nlrp3 inflammasome inhibitionINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 1546US11773058B2Sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Granted Oct 3, 2023·0 cites·20 claims
- 1646US2022289692A1Nlrp3 inhibitorsINFLAZOME LTD·Filed 2020·Application pending·0 cites
- 1745US2022106289A1Nlrp3 inhibitorsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 1844US12030879B2Sulfonyl acetamides as NLRP3 inhibitorsINFLAZOME LTD·Filed 2019·Granted Jul 9, 2024·0 cites·23 claims
- 1943US2020399242A1Novel compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 2041US2020361895A1Novel sulfonamide carboxamide compoundsINFLAZOME LTD·Filed 2018·Application pending·0 cites
- 2139US2021261512A1Novel compoundsINFLAZOME LTD·Filed 2019·Application pending·0 cites
- 2233US11390628B2Preparation of buprenorphineRIVER STONE BIOTECH LLC·Filed 2018·Granted Jul 19, 2022·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →